Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 14
Review
Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,820 | Dovepress* | 5,613+ | 183 | 5,796 | |
| PubMed Central* | 5,207 | 576 | 5,783 | ||
| Totals | 10,820 | 759 | 11,579 | ||
| *Since 5 January 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 0 | 3 |
View citations on PubMed Central and Google Scholar